In this edition of the SpheraNOW podcast, James Tehrani, Spark's editor in chief speaks with Dr. Adrian Mulholland, a chemistry professor at the University of Bristol’s Centre for Computational Chemistry in England, about the VR technology he and his team are developing to research anti-viral medications for COVID-19 and other diseases.